ALX Oncology Holdings (ALXO)
(Delayed Data from NSDQ)
$0.66 USD
+0.07 (12.68%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $0.66 0.00 (-0.17%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, ALX Oncology Holdings Inc. has a market cap of $31.33M, which represents its share price of $0.59 multiplied by its outstanding shares number of 53.40M. As a small-cap company, ALXO's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ALXO 0.66 +0.07(12.68%)
Will ALXO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ALXO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALXO
ALX Oncology Holdings (ALXO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?
ALXO: What are Zacks experts saying now?
Zacks Private Portfolio Services
ALX Oncology Holdings (ALXO) Loses -27.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Other News for ALXO
ALX Oncology to Report Second Quarter 2025 Financial Results on August 12, 2025 | ALXO Stock News
Jazz Pharmaceuticals: I See Big Potential In This Stock As An Investor
ALX Oncology Confirms Directors at Annual Meeting
ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference | ALXO Stock News
Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and ALX Oncology Holdings (ALXO)